Physician

Emma Greear, DO

According to 2025 Medicare claims, Emma Greear, DO (NPI: 1467943845) practices rheumatology in the Kingsport-Bristol, TN-VA market, with the plurality of this provider's patient population coming from Sullivan, TN. This provider's primary affiliated billing organization is ARTHRITIS ASSOCIATES OF KINGSPORT, PLLC (NPI: 1750434619; TIN: 621523356) and primary practice location at 37660-7390.

Greear's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 104 traditional Medicare patients, billed 5,470 HCPCS/CPT codes, and received $105,246 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 916 prescription claims across 157 beneficiaries totaling $485,173 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2021 DME data shows 12 claims. Open Payments data shows 132 records totaling $2,724. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $14,631 and ending at $485,173. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$53K$105K2023 Medicare payment: $12,852 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $105,246 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202331470$12,852
20241045,470$105,246

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$243K$485K2018 Drug cost: $14,631 (USD; Tot_Drug_Cst)2019 Drug cost: $7,247 (USD; Tot_Drug_Cst)2020 Drug cost: $34,084 (USD; Tot_Drug_Cst)2021 Drug cost: $5,535 (USD; Tot_Drug_Cst)2022 Drug cost: $17,959 (USD; Tot_Drug_Cst)2023 Drug cost: $11,680 (USD; Tot_Drug_Cst)2024 Drug cost: $485,173 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182784$14,631
201933186$7,247
202039304$34,084
202143236$5,535
202237144$17,959
202372198$11,680
2024157916$485,173

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$31$622021 Medicare payment: $62 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R12$62
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more5555$125
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more49108$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5062$59
73130X-ray of hand, minimum of 3 views3262$18
76881Complete ultrasound scan of joint2542$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab21588$154,955
Hydroxychloroquine SulfateHydroxychloroquine Sulfate1349,631$5,486
ColchicineColchicine523,277$2,741
MethotrexateMethotrexate Sodium1376,803$2,656
LeflunomideLeflunomide481,680$1,893

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.132$2,724Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Emma Greear, DO?

Tedicare shows public-source Medicare data for Emma Greear, DO (NPI 1467943845), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emma Greear, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Emma Greear, DO?

Emma Greear, DO is linked to ARTHRITIS ASSOCIATES OF KINGSPORT, PLLC (billing NPI 1750434619) in the available physician profile data.

Does Emma Greear, DO have Open Payments data?

Emma Greear, DO has 132 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.